Table 16b:
Mortality Outcomes in the PLCO and ERSPC Trials
| Prostate Cancer RR (95% CI) | Prostate Cancer ARD 95% CI (Screen – Control) | All-Cause Mortality RR (95% CI) | |
|---|---|---|---|
| PLCO RCT | 1.09 (0.87–1.36) | 3.4–3.7/10,000 | 0.96 (0.93–1.10) |
| ERSPC RCT | 0.79 (0.67–0.92) | −4.4 to −3.5/10,000 | 0.99 (0.97–1.10) |
Abbreviations: ARD, absolute risk difference; ERSPC, European Randomized Study of Screening for Prostate Cancer; PLCO, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial; RCT, randomized controlled trial; RR, relative risk.